Cargando…

Increased Expression of LYNX1 in Ovarian Serous Cystadenocarcinoma Predicts Poor Prognosis

Few studies have reported the function of LYNX1 in ovarian cancer. We retrieved LYNX1 gene expression data and clinical information of 376 patients with ovarian cancer from The Cancer Genome Atlas (TCGA) project website. Wilcoxon signed-rank test and logistic regression were used to analyze the rela...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hui, Wang, Ao, Ma, Yushan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710416/ https://www.ncbi.nlm.nih.gov/pubmed/33299855 http://dx.doi.org/10.1155/2020/1392674

Ejemplares similares

Long non-coding RNA FOXP4-AS1 is a prognostic biomarker and associated with immune infiltrates in ovarian serous cystadenocarcinoma
por: Liao, Cheng, et al.
Publicado: (2021)

Low expression of acyl-CoA thioesterase 13 is associated with poor prognosis in ovarian serous cystadenocarcinoma
por: Lv, Xiaofeng, et al.
Publicado: (2023)

Gastric metastasis of ovarian serous cystadenocarcinoma
por: Yang, Shiqiang
Publicado: (2018)

Stem Cell-Associated Signatures Help to Predict Diagnosis and Prognosis in Ovarian Serous Cystadenocarcinoma
por: Li, Li, et al.
Publicado: (2023)

Abnormal expressions of PURPL, miR-363-3p and ADAM10 predicted poor prognosis for patients with ovarian serous cystadenocarcinoma
por: Zhang, Ruitao, et al.
Publicado: (2023)

Gene Expression Subtyping Reveals Immune alterations:TCGA Database for Prognosis in Ovarian Serous Cystadenocarcinoma
por: Feng, Chunxia, et al.
Publicado: (2021)

Comprehensive analysis of the expression of sodium/potassium-ATPase α subunits and prognosis of ovarian serous cystadenocarcinoma
por: Huang, Wei, et al.
Publicado: (2020)

A Five-Gene Expression Signature Predicts Clinical Outcome of Ovarian Serous Cystadenocarcinoma
por: Liu, Li-Wei, et al.
Publicado: (2016)

Serous cystadenocarcinoma of the spleen
por: Chou, Chung Kuao, et al.
Publicado: (2017)

Mining TCGA database for gene expression in ovarian serous cystadenocarcinoma microenvironment
por: Xu, Youzheng, et al.
Publicado: (2021)

Identification and validation of a novel anoikis-related signature for predicting prognosis and immune landscape in ovarian serous cystadenocarcinoma
por: Zhu, Yu-Ting, et al.
Publicado: (2023)

Expression of Yes-associated protein 1 and its clinical significance in ovarian serous cystadenocarcinoma
por: Cho, Sang Yeon, et al.
Publicado: (2017)

TRPs in Ovarian Serous Cystadenocarcinoma: The Expression Patterns, Prognostic Roles, and Potential Therapeutic Targets
por: Zhang, Cheng, et al.
Publicado: (2022)

A novel ferroptosis related gene signature is associated with prognosis in patients with ovarian serous cystadenocarcinoma
por: Yu, Zhixiang, et al.
Publicado: (2021)

Two protein-coding genes act as a novel clinical signature to predict prognosis in patients with ovarian serous cystadenocarcinoma
por: Zhang, Jue, et al.
Publicado: (2018)

Comprehensive analysis of LDHAP5 pseudogene expression and potential pathogenesis in ovarian serous cystadenocarcinoma
por: Lin, Shitong, et al.
Publicado: (2020)

Genome-Wide Identification and Validation of Gene Expression Biomarkers in the Diagnosis of Ovarian Serous Cystadenocarcinoma
por: Zalfa, Francesca, et al.
Publicado: (2022)

An Immune-Related Gene-Based Signature as Prognostic Tool in Ovarian Serous Cystadenocarcinoma
por: Shi, Fengjuan, et al.
Publicado: (2021)

Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas
por: Wang, Aichun, et al.
Publicado: (2015)

Estimation of Prognostic Marker Genes by Public Microarray Data in Patients with Ovarian Serous Cystadenocarcinoma
por: Yang, San-Duk, et al.
Publicado: (2016)

Development and Validation of an RNA-Binding Protein-Based Prognostic Model for Ovarian Serous Cystadenocarcinoma
por: He, Yunan, et al.
Publicado: (2020)

Assessment of Significant Pathway Signaling and Prognostic Value of GNG11 in Ovarian Serous Cystadenocarcinoma
por: Jiang, Ming-Min, et al.
Publicado: (2021)

KRT19 is a Promising Prognostic Biomarker and Associates with Immune Infiltrates in Serous Ovarian Cystadenocarcinoma
por: Sun, Zhe, et al.
Publicado: (2023)

Pancreatic serous cystadenocarcinoma with invasive growth into the colon and spleen
por: Cho, Wontae, et al.
Publicado: (2011)

Identification of bromodomain-containing proteins prognostic value and expression significance based on a genomic landscape analysis of ovarian serous cystadenocarcinoma
por: Zhang, Juan, et al.
Publicado: (2022)

High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma
por: Cui, Xuelian, et al.
Publicado: (2015)

Identification of biomarkers complementary to homologous recombination deficiency for improving the clinical outcome of ovarian serous cystadenocarcinoma
por: Shi, Zhiwen, et al.
Publicado: (2021)

Pancreatic Serous Cystadenocarcinoma: A Case Report and Review of the Literature
por: King, Jonathan C., et al.
Publicado: (2009)

Serous cystadenocarcinoma of the pancreas: report of a case and management reflections
por: Bramis, K, et al.
Publicado: (2012)

Hepatic resection of metastatic tumor from serous cystadenocarcinoma of the ovary.
por: Lee, Jong Hoon, et al.
Publicado: (2002)

The circular RNA expression profile in ovarian serous cystadenocarcinoma reveals a complex circRNA–miRNA regulatory network
por: Zhuang, Minhui, et al.
Publicado: (2021)

High expression of Tie-2 predicts poor prognosis in primary high grade serous ovarian cancer
por: Sopo, Minna, et al.
Publicado: (2020)

Serous cystadenocarcinoma of the mesentery in a man: case report and review of literature
por: Obuchi, Toru, et al.
Publicado: (2014)

A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma
por: Guo, Wenna, et al.
Publicado: (2018)

Differential Expression Patterns of Lynx Proteins and Involvement of Lynx1 in Prepulse Inhibition
por: Sherafat, Yasmine, et al.
Publicado: (2021)

Patterns of variation in reproductive parameters in Eurasian lynx (Lynx lynx)
por: Nilsen, Erlend B., et al.
Publicado: (2011)

Update of the helminth fauna in Eurasian lynx (Lynx lynx) in Poland
por: Kołodziej-Sobocińska, Marta, et al.
Publicado: (2018)

Membranous glomerulonephritis in the Iberian lynx (Lynx pardinus)
por: Jiménez, Ma Ángeles, et al.
Publicado: (2008)

LPAR1 regulates the development of intratumoral heterogeneity in ovarian serous cystadenocarcinoma by activating the PI3K/AKT signaling pathway
por: Cui, Ran, et al.
Publicado: (2019)

Targetable IDH1 mutation identified in a rare case of pancreatic serous cystadenocarcinoma but not a series of serous cystadenomas
por: Zhang, Yuxi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_orlpofdei0b0njij06v4b1gvbt